These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12605123)

  • 1. Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo.
    Spriewald BM; Billing JS; Jenkins S; Wheeler P; Steger U; Bushell A; Hyde K; Morris PJ; Wood KJ
    Transplantation; 2003 Feb; 75(4):537-41. PubMed ID: 12605123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathymic delivery of plasmid-encoding endoplasmic reticulum signal-sequence-deleted MHC class I alloantigen can induce long-term allograft survival.
    Spriewald BM; Ensminger SM; Jenkins S; Morris PJ; Wood KJ
    Transpl Int; 2004 Sep; 17(8):458-62. PubMed ID: 15372145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo.
    Fry JW; Morris PJ; Wood KJ
    Gene Ther; 2002 Feb; 9(3):220-6. PubMed ID: 11859426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
    Wong W; Billing JS; Stranford SA; Hyde K; Fry J; Morris PJ; Wood KJ
    Hum Gene Ther; 2003 Apr; 14(6):577-90. PubMed ID: 12718767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
    Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
    Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of operational tolerance and generation of regulatory cells after intratracheal delivery of alloantigen combined with nondepleting anti-CD4 monoclonal antibody.
    Aramaki O; Shirasugi N; Akiyama Y; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Niimi M
    Transplantation; 2003 Nov; 76(9):1305-14. PubMed ID: 14627908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of specific prolongation of class I-mismatched skin grafts induced by retroviral gene therapy.
    Mayfield RS; Hayashi H; Sawada T; Bergen K; LeGuern C; Sykes M; Sachs DH; Iacomini J
    Eur J Immunol; 1997 May; 27(5):1177-81. PubMed ID: 9174608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
    Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
    Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
    Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
    Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD27/CD70, CD134/CD134 ligand, and CD30/CD153 pathways are independently essential for generation of regulatory cells after intratracheal delivery of alloantigen.
    Aramaki O; Shirasugi N; Akiyama Y; Shibutani S; Takayama T; Shimazu M; Kitajima M; Ikeda Y; Okumura K; Yagita H; Niimi M
    Transplantation; 2003 Sep; 76(5):772-6. PubMed ID: 14501851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.
    Warnecke G; Bushell A; Nadig SN; Wood KJ
    Transplantation; 2007 Jun; 83(11):1459-65. PubMed ID: 17565319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
    Niimi M; Witzke O; Bushell A; Hara M; Morris PJ; Wood KJ
    Transplantation; 2000 Nov; 70(10):1524-8. PubMed ID: 11118100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.